Late-Breaking Data at ACC.21 Show XARELTO® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization ...Middle East

RARITAN, N.J., May 16, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced...

Hence then, the article about late breaking data at acc 21 show xarelto rivaroxaban plus aspirin significantly reduced total ischemic events in peripheral artery disease pad patients after lower extremity revascularization was published today ( Sunday 16/05/2021 - 03:49 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Late-Breaking Data at ACC.21 Show XARELTO® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization )

Also on site :

• Widow who lost life savings in romances scams died in Ghana crash after traveling ‘for marriage’
• New York lawsuits target prediction market giants Coinbase and Gemini in major showdown
• Ralph Fiennes, Viggo Mortensen, Charlotte Rampling, Katherine Langford & More Set For István Szabó’s ‘Embers’; Filming Underway & First Looks Revealed With Embankment Aboard For Cannes Market